Tony Michael Argenbright

Array ( [id] => 10898096 [patent_doc_number] => 08921309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Lipopeptide compounds and their use' [patent_app_type] => utility [patent_app_number] => 13/128661 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45128 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6444792 [patent_doc_number] => 20100144677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHOD FOR SCREENING AGENTS FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/622010 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18477 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144677.pdf [firstpage_image] =>[orig_patent_app_number] => 12622010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000903 [patent_doc_number] => 20110117195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'METHOD FOR IMPROVING MYOCARDIAL INFARCTION BY INTRAMYOCARDIAL OR TRANSENDOCARDIAL INJECTION OF PEPTIDE NANOFIBERS' [patent_app_type] => utility [patent_app_number] => 12/620890 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117195.pdf [firstpage_image] =>[orig_patent_app_number] => 12620890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222331 [patent_doc_number] => 20100056425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Absorption enhancers such as E.G. BHT, BHA or propyl gallate' [patent_app_type] => utility [patent_app_number] => 12/591086 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5687 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056425.pdf [firstpage_image] =>[orig_patent_app_number] => 12591086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6443574 [patent_doc_number] => 20100144593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Pharmaceutical Compositions and Methods for Insulin Treatment' [patent_app_type] => utility [patent_app_number] => 12/614335 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4594 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144593.pdf [firstpage_image] =>[orig_patent_app_number] => 12614335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486259 [patent_doc_number] => 20100285494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610490 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77219 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285494.pdf [firstpage_image] =>[orig_patent_app_number] => 12610490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490783 [patent_doc_number] => 08030270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Methods for identifying GLP-1 secretagogues' [patent_app_type] => utility [patent_app_number] => 12/610674 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 77268 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030270.pdf [firstpage_image] =>[orig_patent_app_number] => 12610674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498127 [patent_doc_number] => 20100286168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610885 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77208 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286168.pdf [firstpage_image] =>[orig_patent_app_number] => 12610885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267155 [patent_doc_number] => 20100298333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610967 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 77208 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298333.pdf [firstpage_image] =>[orig_patent_app_number] => 12610967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498335 [patent_doc_number] => 20100286172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610682 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77216 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286172.pdf [firstpage_image] =>[orig_patent_app_number] => 12610682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497777 [patent_doc_number] => 20100286153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610918 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77219 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286153.pdf [firstpage_image] =>[orig_patent_app_number] => 12610918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496700 [patent_doc_number] => 20100286111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610877 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77219 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286111.pdf [firstpage_image] =>[orig_patent_app_number] => 12610877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588914 [patent_doc_number] => 20100291589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/610639 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77208 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291589.pdf [firstpage_image] =>[orig_patent_app_number] => 12610639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248995 [patent_doc_number] => 20100137293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL' [patent_app_type] => utility [patent_app_number] => 12/609599 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77216 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137293.pdf [firstpage_image] =>[orig_patent_app_number] => 12609599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580852 [patent_doc_number] => 20110294735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'MECHANISM OF NEUROMEDIN U ACTION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/122783 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12196 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294735.pdf [firstpage_image] =>[orig_patent_app_number] => 13122783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401896 [patent_doc_number] => 08691949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Peptide having anti-diabetic activity and use thereof' [patent_app_type] => utility [patent_app_number] => 13/123784 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7991 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13123784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701536 [patent_doc_number] => 08394758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Tumor-targeting peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/607334 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5374 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12607334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937352 [patent_doc_number] => 20110212891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'AZEPINONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/126533 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21324 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212891.pdf [firstpage_image] =>[orig_patent_app_number] => 13126533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6456391 [patent_doc_number] => 20100105781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'ABUSE RESISTANT LYSINE AMPHETAMINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/582838 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 26273 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105781.pdf [firstpage_image] =>[orig_patent_app_number] => 12582838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636943 [patent_doc_number] => 20100035868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'METHODS OF TREATMENT OF UTERINE PATHOLOGICAL CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/574451 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10240 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035868.pdf [firstpage_image] =>[orig_patent_app_number] => 12574451 [rel_patent_id] =>[rel_patent_doc_number] =>)